Sivik Global Healthcare LLC

GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$175.0M2026 Q3
Positions35
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.46.2%

Sivik Global Healthcare LLC reported 35 positions worth $175.0M as of September 30, 2026 (13F filed October 13, 2026). Largest holding: XBI (16.2%). Biggest move: exit CALL- BSX 100 @ 75 EXP 04/17/2026 ($5.0M).

10 / 35 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 XBISPDR Series$28.4M16.21%180,000——-7.5%
▸ 2 HUMHumana$6.8M3.86%17,700——+20.9%
▸ 3 JNJJohnson & Johnson$6.4M3.63%24,000——+6.7%
▸ 4 MRKMerck$5.8M3.32%40,000——-0.6%
▸ 5 ABBVAbbVie$5.8M3.29%22,000——+12.6%
▸ 6 TMOThermo Fisher Scientific$5.7M3.28%8,500——+2.4%
▸ 7 CAHCardinal Health$5.6M3.18%25,000——+27.6%
▸ 8 MCKMckesson$5.5M3.17%6,500——+29.4%
▸ 9 DHRDanaher$5.5M3.16%25,000——+3.8%
▸ 10 UNHUnitedHealth$5.5M3.15%15,000——+12.2%

Pro Feature

The remaining 25 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Sivik Global Healthcare LLC hold as of Q3 2026?

Sivik Global Healthcare LLC reported 35 positions worth $175.0M in its Q3 2026 13F filing. Largest positions: XBI (16.2%), HUM (3.9%), JNJ (3.6%), MRK (3.3%) and ABBV (3.3%).

What did Sivik Global Healthcare LLC buy in Q3 2026?

New positions: CNC, RVTY, BRKR, MDT and RGEN (12 in all). Added to: XBI, ELV, EHC, ABT and EW (14 in all).

What did Sivik Global Healthcare LLC sell in Q3 2026?

Reduced: WAT, LLY, HUM, BIO and MTD. Sold out entirely: CALL- BSX 100 @ 75 EXP 04/17/2026, ISRG, AZN, BSX and THC (11 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.